9 results on '"Nick Loman"'
Search Results
2. Genomics-informed outbreak investigations of SARS-CoV-2 using civet.
- Author
-
Áine O'Toole, Verity Hill, Ben Jackson, Rebecca Dewar, Nikita Sahadeo, Rachel Colquhoun, Stefan Rooke, J T McCrone, Kate Duggan, Martin P McHugh, Samuel M Nicholls, Radoslaw Poplawski, COVID-19 Genomics UK (COG-UK) Consortium, COVID-19 Impact Project (Trinidad & Tobago Group), David Aanensen, Matt Holden, Tom Connor, Nick Loman, Ian Goodfellow, Christine V F Carrington, Kate Templeton, and Andrew Rambaut
- Subjects
Public aspects of medicine ,RA1-1270 - Abstract
The scale of data produced during the SARS-CoV-2 pandemic has been unprecedented, with more than 13 million sequences shared publicly at the time of writing. This wealth of sequence data provides important context for interpreting local outbreaks. However, placing sequences of interest into national and international context is difficult given the size of the global dataset. Often outbreak investigations and genomic surveillance efforts require running similar analyses again and again on the latest dataset and producing reports. We developed civet (cluster investigation and virus epidemiology tool) to aid these routine analyses and facilitate virus outbreak investigation and surveillance. Civet can place sequences of interest in the local context of background diversity, resolving the query into different 'catchments' and presenting the phylogenetic results alongside metadata in an interactive, distributable report. Civet can be used on a fine scale for clinical outbreak investigation, for local surveillance and cluster discovery, and to routinely summarise the virus diversity circulating on a national level. Civet reports have helped researchers and public health bodies feedback genomic information in the appropriate context within a timeframe that is useful for public health.
- Published
- 2022
- Full Text
- View/download PDF
3. Genomic Surveillance of Yellow Fever Virus Epizootic in São Paulo, Brazil, 2016 - 2018.
- Author
-
Sarah C Hill, Renato de Souza, Julien Thézé, Ingra Claro, Renato S Aguiar, Leandro Abade, Fabiana C P Santos, Mariana S Cunha, Juliana S Nogueira, Flavia C S Salles, Iray M Rocco, Adriana Y Maeda, Fernanda G S Vasami, Louis du Plessis, Paola P Silveira, Jaqueline G de Jesus, Joshua Quick, Natália C C A Fernandes, Juliana M Guerra, Rodrigo A Réssio, Marta Giovanetti, Luiz C J Alcantara, Cinthya S Cirqueira, Josué Díaz-Delgado, Fernando L L Macedo, Maria do Carmo S T Timenetsky, Regiane de Paula, Roberta Spinola, Juliana Telles de Deus, Luís F Mucci, Rosa Maria Tubaki, Regiane M T de Menezes, Patrícia L Ramos, Andre L de Abreu, Laura N Cruz, Nick Loman, Simon Dellicour, Oliver G Pybus, Ester C Sabino, and Nuno R Faria
- Subjects
Immunologic diseases. Allergy ,RC581-607 ,Biology (General) ,QH301-705.5 - Abstract
São Paulo, a densely inhabited state in southeast Brazil that contains the fourth most populated city in the world, recently experienced its largest yellow fever virus (YFV) outbreak in decades. YFV does not normally circulate extensively in São Paulo, so most people were unvaccinated when the outbreak began. Surveillance in non-human primates (NHPs) is important for determining the magnitude and geographic extent of an epizootic, thereby helping to evaluate the risk of YFV spillover to humans. Data from infected NHPs can give more accurate insights into YFV spread than when using data from human cases alone. To contextualise human cases, identify epizootic foci and uncover the rate and direction of YFV spread in São Paulo, we generated and analysed virus genomic data and epizootic case data from NHPs in São Paulo. We report the occurrence of three spatiotemporally distinct phases of the outbreak in São Paulo prior to February 2018. We generated 51 new virus genomes from YFV positive cases identified in 23 different municipalities in São Paulo, mostly sampled from NHPs between October 2016 and January 2018. Although we observe substantial heterogeneity in lineage dispersal velocities between phylogenetic branches, continuous phylogeographic analyses of generated YFV genomes suggest that YFV lineages spread in São Paulo at a mean rate of approximately 1km per day during all phases of the outbreak. Viral lineages from the first epizootic phase in northern São Paulo subsequently dispersed towards the south of the state to cause the second and third epizootic phases there. This alters our understanding of how YFV was introduced into the densely populated south of São Paulo state. Our results shed light on the sylvatic transmission of YFV in highly fragmented forested regions in São Paulo state and highlight the importance of continued surveillance of zoonotic pathogens in sentinel species.
- Published
- 2020
- Full Text
- View/download PDF
4. The distinct features of microbial 'dysbiosis' of Crohn's disease do not occur to the same extent in their unaffected, genetically-linked kindred.
- Author
-
Umer Zeeshan Ijaz, Christopher Quince, Laura Hanske, Nick Loman, Szymon T Calus, Martin Bertz, Christine A Edwards, Daniel R Gaya, Richard Hansen, Paraic McGrogan, Richard K Russell, and Konstantinos Gerasimidis
- Subjects
Medicine ,Science - Abstract
BACKGROUND/AIMS:Studying the gut microbiota in unaffected relatives of people with Crohn's disease (CD) may advance our understanding of the role of bacteria in disease aetiology. METHODS:Faecal microbiota composition (16S rRNA gene sequencing), genetic functional capacity (shotgun metagenomics) and faecal short chain fatty acids (SCFA) were compared in unaffected adult relatives of CD children (CDR, n = 17) and adult healthy controls, unrelated to CD patients (HUC, n = 14). The microbiota characteristics of 19 CD children were used as a benchmark of CD 'dysbiosis'. RESULTS:The CDR microbiota was less diverse (p = 0.044) than that of the HUC group. Local contribution of β-diversity analysis showed no difference in community structure between the CDR and HUC groups. Twenty one of 1,243 (1.8%) operational taxonomic units discriminated CDR from HUC. The metagenomic functional capacity (p = 0.207) and SCFA concentration or pattern were similar between CDR and HUC (p>0.05 for all SCFA). None of the KEGG metabolic pathways were different between these two groups. Both of these groups (HUC and CDR) had a higher microbiota α-diversity (CDR, p = 0.026 and HUC, p
- Published
- 2017
- Full Text
- View/download PDF
5. A cross-sectional survey of bacterial species in plaque from client owned dogs with healthy gingiva, gingivitis or mild periodontitis.
- Author
-
Ian J Davis, Corrin Wallis, Oliver Deusch, Alison Colyer, Lisa Milella, Nick Loman, and Stephen Harris
- Subjects
Medicine ,Science - Abstract
Periodontal disease is the most widespread oral disease in dogs which if left untreated results in significant pain to the pet and loss of dentition. The objective of this study was to identify bacterial species in canine plaque that are significantly associated with health, gingivitis and mild periodontitis (
- Published
- 2013
- Full Text
- View/download PDF
6. A disruptive sequencer meets disruptive publishing [version 1; referees: not peer reviewed]
- Author
-
Nick Loman, Sarah Goodwin, Hans Jansen, and Matt Loose
- Subjects
Editorial ,Articles ,Genomics ,nanopore ,MinION ,sequencing ,Oxford nanopore technology ,MinION access programme ,MinION analysis consortium - Abstract
Nanopore sequencing was recently made available to users in the form of the Oxford Nanopore MinION. Released to users through an early access programme, the MinION is made unique by its tiny form factor and ability to generate very long sequences from single DNA molecules. The platform is undergoing rapid evolution with three distinct nanopore types and five updates to library preparation chemistry in the last 18 months. To keep pace with the rapid evolution of this sequencing platform, and to provide a space where new analysis methods can be openly discussed, we present a new F1000Research channel devoted to updates to and analysis of nanopore sequence data.
- Published
- 2015
- Full Text
- View/download PDF
7. PrimalSeq:Generation of tiled virus amplicons for MiSeq sequencing v1
- Author
-
Nate Matteson, Nathan Grubaugh, Karthik Gangavarapu, Josh Quick, Nick Loman, and Kristian Andersen
- Subjects
Biology ,Amplicon ,Virology ,Virus - Abstract
Generated in collaboration by the Loman, Andersen, and Grubaugh labs. For general use of the protocol and primer design, please cite: Quick, J. et al. Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples. Nature Protocols 12 (6), 1261-1276 (2017)https://www.nature.com/nprot/journal/v12/n6/abs/nprot.2017.066.html For measuring intrahost virus genetic diversity and calling variants using iVar, please cite: Grubaugh, ND. et al. An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar. Genome Biology 20,8 (2019) https://genomebiology.biomedcentral.com/articles/10.1186/s13059-018-1618-7 The general approach to this protocol is to amplify the virus genome in small (~400 bp) overlapping fragments using two highly multiplexed PCR reactions (where the overlapping segments are in separate reactions). The amplicons are combined after PCR and are the correct size for library preparation and paired-end 250 nt sequencing using the Illumina MiSeq. Version 4 notes: This protocol has been updated to include considerations for measuring intra-batch contamination through the introduction of sample-specific barcoded spike-ins. All of the primers are now listed in a separate spreadsheet. We currently have 400 bp amplicon schemes for Zika virus, West Nile virus (North America lineage I genotype), Usutu virus, and chikungunya virus (ECSA genotype). More will be made available soon. You can build your own primer sets by using Primal Scheme. Overview of tiled virus amplicon sequencing protocol
- Published
- 2020
- Full Text
- View/download PDF
8. ABPHM15 EtherPad Archive
- Author
-
Jennifer Gardy, Nick Loman, Anthony Underwood, Willem van Schaik, Tom Connor, Torsten Seemann, Marc Lipsitch, Esther Robinson, Phil Ashton, Jennifer Gardy, Nick Loman, Anthony Underwood, Willem van Schaik, Tom Connor, Torsten Seemann, Marc Lipsitch, Esther Robinson, and Phil Ashton
- Published
- 2015
- Full Text
- View/download PDF
9. Sequencing of the Francisella tularensis strain Schu 4 genome reveals the shikimate and purine metabolic pathways, targets for the construction of a rationally attenuated auxotrophic vaccine
- Author
-
Kerri Mack, Siv G. E. Andersson, Jan Karlsson, Mark J. Pallen, Thomas Svensson, Richard W. Titball, Karin Hjalmarsson, Michael Popek, Katherine A. Brown, Nick Loman, Brendan W. Wren, Anders Sjöstedt, Nicola Chatwell, Richard G. Prior, Kerstin Williams, Ivica Tamas, Luther E. Lindler, Petra C. F. Oyston, and Gunnar Sandström
- Subjects
Genetics ,biology ,Nucleic acid sequence ,Virulence ,Shikimic Acid ,Sequence Analysis, DNA ,medicine.disease ,biology.organism_classification ,Vaccines, Attenuated ,Applied Microbiology and Biotechnology ,Genome ,Models, Biological ,Tularemia ,Plasmid ,Genes, Bacterial ,Purines ,Bacterial Vaccines ,medicine ,Shikimate pathway ,Francisella tularensis ,Molecular Biology ,Gene ,Genome, Bacterial - Abstract
Francisella tularensis is the etiological agent of tularemia, a serious disease in several Northern hemisphere countries. The organism has fastidious growth requirements and is very poorly understood at the genetic and molecular levels. Given the lack of data on this organism, we undertook the sample sequencing of its genome. A random library of DNA fragments from a highly virulent strain (Schu 4) of F. tularensis was constructed and the nucleotide sequences of 13,904 cloned fragments were determined and assembled into 353 contigs. A total of 1.83 Mb of nucleotide sequence was obtained that had a G+C content of 33.2%. Genes located on plasmids pOM1 and pNFL10, which had been previously isolated from low virulence strains of F. tularensis, were absent but all of the other known F. tularensis genes were represented in the assembled data. F. tularensis Schu4 was able to grow in the absence of aromatic amino acids and orthologues of genes which could encode enzymes in the shikimate pathway in other bacteria were identified in the assembled data. Genes that could encode all of the enzymes in the purine biosynthetic and most of the en- zymes in the purine salvage pathways were also identified. This data will be used to develop defined rationally attenuated mutants of F. tularensis, which could be used as replacements for the existing genetically undefined live vaccine strain.
- Published
- 2000
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.